<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01089907</url>
  </required_header>
  <id_info>
    <org_study_id>200906028R</org_study_id>
    <nct_id>NCT01089907</nct_id>
  </id_info>
  <brief_title>Genomic Changes in Childhood Acute Lymphoblastic Leukemia</brief_title>
  <official_title>Genomics Evolution in Childhood Acute Lymphoblastic Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the genomics with cell cycle and lymphocyte differentiation in disease, remission
      and relapse of childhood acute lymphoblastic leukemia. Then correlate these data with age,
      white cell count, cytogenetic changes, response to the chemotherapy and prognosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to know the genomic evolution of childhood acute lymphoblastic leukemia, we will
      collect bone marrow (10c.c.) at diagnosis, remission and relapse. We will do the following
      genes in addition to gene-chip including IKZF1,ETV6, EBF1, NR3C1, RAG1/G2, TCF3, BTLA,
      PAX5,LEF1, ERG and VPREB1.We will study the gene dosages and degree of methylation. The
      estimated patients numbers will be 300-400. Then we will correlate these data with
      patients'age, white blood cell count at diagnosis, cytogenetic abnormalities, response to the
      chemotherapy and prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Acute Lymphoblastic Leukemia</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      bone marrow, peripheral blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Acute lymphoblastic leukemia patients under 18 years of age
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients diagnosed as acute lymphoblastic leukemia

          2. age less than or equal to 18 years old

          3. signed informed consent

        Exclusion Criteria:

          1. who is not acute lymphoblastic leukemia

          2. who did not sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong-Tsamn Lin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital,Taipei,Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dong-Tsamn Lin, M.D.</last_name>
    <phone>02-23123456</phone>
    <phone_ext>65399</phone_ext>
    <email>dtlin@ntuh.gov.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>young-li Yang, M.D.</last_name>
    <phone>02-23123456</phone>
    <phone_ext>71311</phone_ext>
    <email>yangylmd@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dong-Tsamn Lin, M.D.</last_name>
      <phone>02-23123456</phone>
      <phone_ext>65399</phone_ext>
      <email>dtlin@ntuh.gov.tw</email>
    </contact>
    <contact_backup>
      <last_name>Yong-li Yang, M.D.</last_name>
      <phone>02-23123456</phone>
      <phone_ext>71732</phone_ext>
      <email>yangylmd@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Dong-Tsamn Lin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Young-li Yang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2010</study_first_submitted>
  <study_first_submitted_qc>March 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2010</study_first_posted>
  <last_update_submitted>March 18, 2010</last_update_submitted>
  <last_update_submitted_qc>March 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>Lin Dong-Tsamn</name_title>
    <organization>National Taiwan University Hospital</organization>
  </responsible_party>
  <keyword>genomic</keyword>
  <keyword>childhood</keyword>
  <keyword>acute lymphoblastic leukemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

